Table 2.

Clinical details of patients with PR to VSTs

Patient with PRThird-party or donor-derived VSTNo. of infusionsDetails of PR
Third-party Viremia improved from 4400 to <100 copies per mL 
Third-party Viremia improved from 1 million to 7135 copies per mL after first infusion; no further decrease with second infusion 
Third-party followed by donor-derived Viremia improved from 500 292 to 54 891 copies per mL after first infusion, then to 863 copies per mL after second infusion 
Third-party Viremia decreased from 3140 to <1000 copies per mL with improvement in adenoviral diarrhea 
Third-party No viremia; reduction but not resolution of adenoviral diarrhea 
Donor-derived Viremia worsened from 4694 to 8103 copies per mL after first infusion but decreased to 810 copies per mL after second infusion 
Patient with PRThird-party or donor-derived VSTNo. of infusionsDetails of PR
Third-party Viremia improved from 4400 to <100 copies per mL 
Third-party Viremia improved from 1 million to 7135 copies per mL after first infusion; no further decrease with second infusion 
Third-party followed by donor-derived Viremia improved from 500 292 to 54 891 copies per mL after first infusion, then to 863 copies per mL after second infusion 
Third-party Viremia decreased from 3140 to <1000 copies per mL with improvement in adenoviral diarrhea 
Third-party No viremia; reduction but not resolution of adenoviral diarrhea 
Donor-derived Viremia worsened from 4694 to 8103 copies per mL after first infusion but decreased to 810 copies per mL after second infusion